The Alliance for Pharmacy Compounding (APC) released a best practice guide for compounding pharmacies that offers recommendations on the preparation of ketamine drugs while the advocates criticize FDA for warning consumers about safety risks of compounded ketamine therapies without taking actions to make the treatments safe.